Having trouble viewing this email? View it as a Web page.
What’s New at CBER
You are subscribed to What’s New at CBER for the U.S. Food & Drug Administration (FDA).
This page has been updated recently.
- Application History
- August 3, 2017 Approval Letter – ZOSTAVAX (PDF – 70KB)
- Complete List of Currently Approved NDA and ANDA Application Submissions (PDF – 21KB)
Posted: 8/8/2017; Updated as of 8/2/2017
- Complete List of Licensed Products and Establishments
Posted: 8/8/2017; Updated as of 7/31/2017